Symbiotec Pharmalab Private Limited – FDA 483

An FDA inspection of Synbiotec Pharmalab Limited, a drug substance manufacturer in Indore, India, revealed significant deficiencies in manufacturing controls and quality systems. Observations included inadequate in-process checks for drug substance manufacturing, insufficient equipment requalification, and poor equipment maintenance. Additionally, the firm failed to establish criteria for CAPA effectiveness checks.